Li H, Yang X, Zhang A, Liang G, Sun Y, Zhang J (2024) Age-period-cohort analysis of incidence, mortality and disability-adjusted life years of esophageal cancer in global, regional and national regions from 1990 to 2019. BMC Public Health 24(1):212. https://doi.org/10.1186/s12889-024-17706-8

Article  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  CAS  Google Scholar 

Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, van Grieken NCT, Vogel A, Smyth EC, ESMO Guidelines Committee (2022) Electronic address: clinicalguidelines@esmo.org.Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33(10):992–1004. https://doi.org/10.1016/j.annonc.2022.07.003

Article  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, Gibson M, Grierson P, Hofstetter WL, Ilson DH, Jalal S, Keswani RN, Kim S, Kleinberg LR, Klempner S, Lacy J, Licciardi F, Ly QP, Matkowskyj KA, McNamara M, Miller A, Mukherjee S, Mulcahy MF, Outlaw D, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian NR, Pluchino LA (2023) Esophageal and esophagogastric junction cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 21(4):393–422. https://doi.org/10.6004/jnccn.2023.0019

Article  PubMed  CAS  Google Scholar 

Puhr HC, Prager GW, Ilhan-Mutlu A (2023) How we treat esophageal squamous cell carcinoma. ESMO Open 8(1):100789. https://doi.org/10.1016/j.esmoop.2023.100789

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huang FL, Yu SJ (2018) Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg 41(3):210–215. https://doi.org/10.1016/j.asjsur.2016.10.005

Article  PubMed  Google Scholar 

Watanabe M, Otake R, Kozuki R, Toihata T, Takahashi K, Okamura A, Imamura Y (2020) Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 50(1):12–20. https://doi.org/10.1007/s00595-019-01878-7. Erratum in: Surg Today. 2020 Apr;50(4):425

Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A, Liu T, Schenker M, Yanez P, Tehfe M, Kowalyszyn R, Karamouzis MV, Bruges R, Zander T, Pazo-Cid R, Hitre E, Feeney K, Cleary JM, Poulart V, Cullen D, Lei M, Xiao H, Kondo K, Li M, Ajani JA (2021) First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 398(10294):27–40

Article  PubMed  PubMed Central  CAS  Google Scholar 

Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y, CheckMate 648 Trial Investigators (2022) Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. N Engl J Med 386(5):449–462. https://doi.org/10.1056/NEJMoa2111380

Article  PubMed  CAS  Google Scholar 

Aoyama T, Hara K, Kazama K, Maezawa Y (2022) Clinical impact of nutrition and inflammation assessment tools in gastric cancer treatment. Anticancer Res 42(11):5167–5180. https://doi.org/10.21873/anticanres

Article  PubMed  CAS  Google Scholar 

Aoyama T, Maezawa Y, Hashimoto I, Rino Y, Oshima T (2023) Clinical impact of nutrition and inflammation assessment tools in pancreatic cancer treatment. Anticancer Res 43(9):3849–3860. https://doi.org/10.21873/anticanres.16572

Article  PubMed  Google Scholar 

Aoyama T, Kazama K, Maezawa Y, Hara K (2023) Usefulness of nutrition and inflammation assessment tools in esophageal cancer treatment. In Vivo. 37(1):22–35. https://doi.org/10.21873/invivo.13051

Article  PubMed  PubMed Central  Google Scholar 

Aoyama T, Kato A, Hashimoto I, Maezawa Y, Hara K, Kazama K, Komori K, Tamagawa H, Tamagawa A, Nagasawa S, Cho H, Segami K, Nakazono M, Otani K, Sawazaki S, Numata M, Kamiya N, Yoshizawa S, Kawahara S, Oshima T, Saito A, Yukawa N, Rino Y (2024) The Naples Prognostic Score is an independent prognostic factor for gastric cancer patients who receive curative treatment. In Vivo 38(2):890–896. https://doi.org/10.21873/invivo.13515

Article  PubMed  PubMed Central  Google Scholar 

Miyamoto Y, Hiyoshi Y, Daitoku N, Okadome K, Sakamoto Y, Yamashita K, Kuroda D, Sawayama H, Iwatsuki M, Baba Y, Yoshida N, Baba H (2019) Naples Prognostic Score is a useful prognostic marker in patients with metastatic colorectal cancer. Dis Colon Rectum 62(12):1485–1493. https://doi.org/10.1097/DCR.0000000000001484

Article  PubMed  Google Scholar 

Gu J, Deng S, Jiang Z, Mao F, Xue Y, Qin L, Shi J, Yang J, Li H, Yu J, Liu K, Wu K, Cao Y, Cai K (2023) Modified Naples prognostic score for evaluating the prognosis of patients with obstructive colorectal cancer. BMC Cancer 23(1):941. https://doi.org/10.1186/s12885-023-11435-8.PMID:37798689;PMCID:PMC10557152

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nakagawa N, Yamada S, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y (2020) Clinical implications of Naples Prognostic Score in patients with resected pancreatic cancer. Ann Surg Oncol 27(3):887–895. https://doi.org/10.1245/s10434-019-08047-7

Article  PubMed  Google Scholar 

Rusch VW, Rice TW, Crowley J, Blackstone EH, Rami-Porta R, Goldstraw P (2010) The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. J Thorac Cardiovasc Surg 139(4):819–21

Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196

Article  PubMed  Google Scholar 

Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Takahashi K, Fujikawa H, Aoyama T, Numata M, Tamagawa H, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T (2021) The Impact of Pretherapeutic Naples Prognostic Score on survival in patients with locally advanced esophageal cancer. Ann Surg Oncol 28(8):4530–4539. https://doi.org/10.1245/s10434-020-09549-5

Article  PubMed  Google Scholar 

Feng JF, Zhao JM, Chen S, Chen QX (2021) Naples Prognostic Score: a novel prognostic score in predicting cancer-specific survival in patients with resected esophageal squamous cell carcinoma. Front Oncol 28(11):652537. https://doi.org/10.3389/fonc.2021.652537

Article  Google Scholar 

Xu SJ, Wang PL, Chen C, You CX, Chen RQ, Wu WW, Chen SC (2023) Inflammatory and nutritional status influences outcomes of minimally invasive esophagectomy. World J Surg 47(4):1003–1017. https://doi.org/10.1007/s00268-023-06890-0

Article  PubMed  Google Scholar